• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用解锁核酸(UNA)提高小干扰RNA(siRNA)在体外和体内的性能。

Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo.

作者信息

Laursen Maria B, Pakula Malgorzata M, Gao Shan, Fluiter Kees, Mook Olaf R, Baas Frank, Langklaer Niels, Wengel Suzy L, Wengel Jesper, Kjems Jørgen, Bramsen Jesper B

机构信息

Department of Molecular Biology, Aarhus University, DK-8000 Aarhus, Denmark.

出版信息

Mol Biosyst. 2010 May;6(5):862-70. doi: 10.1039/b918869j. Epub 2010 Feb 9.

DOI:10.1039/b918869j
PMID:20567772
Abstract

Small interfering RNAs (siRNAs) are now established as a favourite tool to reduce gene expression by RNA interference (RNAi) in mammalian cell culture. However, limitations in potency, duration, delivery and specificity of the gene knockdown (KD) are still major obstacles that need further addressing. Recent studies have successfully improved siRNA performance by the introduction of several types of chemical modifications. Here we explore the effect of incorporating unlocked nucleic acid (UNA) into siRNA designs. The acyclic UNA monomers lack the C2'-C3'-bond of the RNA ribose ring and additively decrease nucleic acid duplex thermostability. We show that UNA-modifications of siRNAs are compatible with efficient RNAi and can improve siRNA performance both in vitro and in vivo. In particular, we find that the destabilizing properties of UNA are well suited to enhance the potency of siRNAs which are heavily modified by other chemical modifications such as locked nucleic acid (LNA), C4'hydroxymethyl-DNA (HM), 2'-O-methyl-RNA (OMe), DNA and 2'-Flouro-DNA (F). Interestingly, we find that naked, but UNA-modified siRNAs have dramatically increased biostability in mice and can induce potent KD in a xenograft model of human pancreas cancer. Hereby UNA constitutes an important type of chemical modification for future siRNA designs.

摘要

小干扰RNA(siRNA)现已成为在哺乳动物细胞培养中通过RNA干扰(RNAi)降低基因表达的常用工具。然而,基因敲低(KD)在效力、持续时间、递送和特异性方面的局限性仍然是需要进一步解决的主要障碍。最近的研究通过引入几种化学修饰成功地提高了siRNA的性能。在此,我们探讨了将解锁核酸(UNA)纳入siRNA设计的效果。无环UNA单体缺乏RNA核糖环的C2'-C3'键,并可累加降低核酸双链体的热稳定性。我们表明,siRNA的UNA修饰与高效RNAi兼容,并且可以在体外和体内提高siRNA的性能。特别是,我们发现UNA的去稳定特性非常适合增强被其他化学修饰如锁核酸(LNA)、C4'羟甲基-DNA(HM)、2'-O-甲基-RNA(OMe)、DNA和2'-氟-DNA(F)大量修饰的siRNA的效力。有趣的是,我们发现未经修饰但经过UNA修饰的siRNA在小鼠体内的生物稳定性显著提高,并且可以在人胰腺癌异种移植模型中诱导有效的KD。因此,UNA构成了未来siRNA设计的一种重要化学修饰类型。

相似文献

1
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo.利用解锁核酸(UNA)提高小干扰RNA(siRNA)在体外和体内的性能。
Mol Biosyst. 2010 May;6(5):862-70. doi: 10.1039/b918869j. Epub 2010 Feb 9.
2
Application of small interfering RNAs modified by unlocked nucleic acid (UNA) to inhibit the heart-pathogenic coxsackievirus B3.非锁核酸(UNA)修饰的小干扰 RNA 在抑制心脏亲嗜性柯萨奇病毒 B3 中的应用。
FEBS Lett. 2010 Feb 5;584(3):591-8. doi: 10.1016/j.febslet.2009.12.007. Epub 2010 Jan 13.
3
UNA (unlocked nucleic acid): a flexible RNA mimic that allows engineering of nucleic acid duplex stability.解锁核酸(UNA):一种灵活的RNA模拟物,可用于设计核酸双链体稳定性。
Bioorg Med Chem. 2009 Aug 1;17(15):5420-5. doi: 10.1016/j.bmc.2009.06.045. Epub 2009 Jun 27.
4
Unlocked nucleic acid--an RNA modification with broad potential.非锁核酸——一种具有广泛潜力的 RNA 修饰。
Org Biomol Chem. 2011 May 21;9(10):3591-7. doi: 10.1039/c0ob01085e. Epub 2011 Mar 23.
5
Chemical modification of siRNA.小干扰RNA的化学修饰
Curr Opin Mol Ther. 2010 Apr;12(2):158-67.
6
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.去端胶原蛋白介导的合成小干扰RNA递送用于体内外有效基因沉默
Nucleic Acids Res. 2004 Jul 22;32(13):e109. doi: 10.1093/nar/gnh093.
7
LNA incorporated siRNAs exhibit lower off-target effects compared to 2'-OMethoxy in cell phenotypic assays and microarray analysis.与2'-甲氧基修饰的小干扰RNA相比,锁核酸修饰的小干扰RNA在细胞表型分析和微阵列分析中显示出较低的脱靶效应。
Nucleic Acids Symp Ser (Oxf). 2008(52):25-6. doi: 10.1093/nass/nrn013.
8
Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.通过4'-硫代修饰的小干扰RNA(siRNA)改善哺乳动物细胞中的RNA干扰:与2'-O-烷基修饰联合使用时对siRNA活性和核酸酶稳定性的影响。
J Med Chem. 2006 Mar 9;49(5):1624-34. doi: 10.1021/jm050822c.
9
Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.填补锁核酸(LNA)反义寡核苷酸缺口嵌合体的空白:解锁核酸(UNA)和4'-C-羟甲基-DNA修饰对核糖核酸酶H募集及LNA缺口嵌合体疗效的影响
Mol Biosyst. 2009 Aug;5(8):838-43. doi: 10.1039/b903922h. Epub 2009 May 19.
10
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.锁核酸(LNA)介导的小干扰RNA(siRNA)稳定性和功能的改善。
Nucleic Acids Res. 2005 Jan 14;33(1):439-47. doi: 10.1093/nar/gki193. Print 2005.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
RNA Therapeutics: Bridging Discovery and Clinical Implementation.RNA疗法:连接发现与临床应用
Methods Mol Biol. 2025;2965:1-37. doi: 10.1007/978-1-0716-4742-4_1.
3
Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs.对完全化学稳定的小干扰RNA中七种主链和核糖修饰的位点特异性耐受性的系统评估
Nucleic Acid Ther. 2025 Jun;35(3):137-149. doi: 10.1089/nat.2024.0077. Epub 2025 May 26.
4
Chemical engineering of CRISPR-Cas systems for therapeutic application.用于治疗应用的CRISPR-Cas系统的化学工程。
Nat Rev Drug Discov. 2025 Mar;24(3):209-230. doi: 10.1038/s41573-024-01086-0. Epub 2024 Dec 17.
5
Gene therapy and kidney diseases.基因治疗与肾脏疾病。
Mol Ther Methods Clin Dev. 2024 Sep 6;32(4):101333. doi: 10.1016/j.omtm.2024.101333. eCollection 2024 Dec 12.
6
2'--Alkyl- -Methyluridine Functionalized Passenger Strand Improves RNAi Activity by Modulating the Thermal Stability.2'-烷基-甲基尿苷功能化的乘客链通过调节热稳定性提高RNA干扰活性。
ACS Med Chem Lett. 2024 Jul 16;15(8):1250-1259. doi: 10.1021/acsmedchemlett.4c00140. eCollection 2024 Aug 8.
7
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones.利用延长的核酸骨架提高体内小干扰RNA的功效。
Nat Biotechnol. 2024 Aug 1. doi: 10.1038/s41587-024-02336-7.
8
Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review.基于小干扰RNA的抗细菌和病毒感染疗法的原理、应用及发展挑战:综述
Front Microbiol. 2024 Jun 13;15:1393646. doi: 10.3389/fmicb.2024.1393646. eCollection 2024.
9
Oligonucleotide therapies for nonalcoholic steatohepatitis.用于非酒精性脂肪性肝炎的寡核苷酸疗法。
Mol Ther Nucleic Acids. 2024 Mar 30;35(2):102184. doi: 10.1016/j.omtn.2024.102184. eCollection 2024 Jun 11.
10
Acyclic ()-glycol nucleic acid (-GNA) modification of siRNAs improves the safety of RNAi therapeutics while maintaining potency.无环()-乙二醇核酸(-GNA)修饰的 siRNA 提高了 RNAi 治疗的安全性,同时保持了效力。
RNA. 2023 Apr;29(4):402-414. doi: 10.1261/rna.079526.122. Epub 2023 Feb 1.